Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Clinical Research and Equipment Industry Analysis

UpdatedApr 19, 2026
DataAggregated Company Financials
Companies11
  • 7D11.8%
  • 3M-0.7%
  • 1Y3.0%
  • YTDn/a

The Clinical Research and Equipment industry is up 12% in the last week, with Locus Cell up 76%. Overall in the last year, the industry is flat.

Industry Valuation and Performance

Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 19 Apr 2026NT$34.7bNT$2.5b-NT$767,980,000.0021.7x-45.2x13.9x
Tue, 17 Mar 2026NT$31.4bNT$2.5b-NT$747,966,000.0019.8x-42x12.5x
Thu, 12 Feb 2026NT$33.3bNT$2.4b-NT$689,929,000.0023.8x-48.3x13.7x
Sat, 10 Jan 2026NT$34.0bNT$2.4b-NT$689,929,000.0025.2x-49.3x14x
Mon, 08 Dec 2025NT$37.9bNT$2.4b-NT$670,921,000.0019.6x-56.5x15.5x
Wed, 05 Nov 2025NT$35.1bNT$2.5b-NT$870,437,000.0018.1x-40.4x14.3x
Fri, 03 Oct 2025NT$39.1bNT$2.5b-NT$870,437,000.0019.5x-44.9x15.9x
Sun, 31 Aug 2025NT$34.9bNT$2.5b-NT$819,216,000.0020.7x-42.6x14.2x
Tue, 29 Jul 2025NT$34.5bNT$2.5b-NT$600,003,000.0021.9x-57.4x14x
Thu, 26 Jun 2025NT$33.7bNT$2.5b-NT$600,003,000.0023.3x-56.2x13.7x
Sat, 24 May 2025NT$31.7bNT$2.5b-NT$604,301,000.0022.2x-52.4x12.9x
Mon, 21 Apr 2025NT$31.6bNT$2.5b-NT$540,128,000.0024.3x-58.5x12.8x
Wed, 19 Mar 2025NT$36.9bNT$2.6b-NT$849,328,000.0029.4x-43.5x14.4x
Fri, 14 Feb 2025NT$37.1bNT$2.6b-NT$854,432,000.0023.2x-43.4x14.5x
Sun, 12 Jan 2025NT$36.5bNT$2.6b-NT$854,432,000.0023.1x-42.7x14.2x
Tue, 10 Dec 2024NT$41.1bNT$2.6b-NT$854,432,000.0023.7x-48.1x16x
Thu, 07 Nov 2024NT$42.6bNT$2.5b-NT$712,402,000.0024.2x-59.8x17x
Sat, 05 Oct 2024NT$41.6bNT$2.3b-NT$836,610,000.0022.3x-49.7x18.3x
Mon, 02 Sep 2024NT$41.6bNT$2.3b-NT$836,610,000.0022.2x-49.7x18.3x
Wed, 31 Jul 2024NT$42.4bNT$2.1b-NT$797,765,000.0032.2x-53.1x19.8x
Fri, 28 Jun 2024NT$43.1bNT$2.1b-NT$797,765,000.0034.4x-54x20.2x
Sun, 26 May 2024NT$39.8bNT$2.1b-NT$797,765,000.0032.1x-49.8x18.6x
Tue, 23 Apr 2024NT$38.2bNT$2.1b-NT$923,759,000.0030x-41.4x18.1x
Thu, 21 Mar 2024NT$39.9bNT$2.1b-NT$611,433,000.0032.2x-65.3x19.4x
Sat, 17 Feb 2024NT$44.3bNT$2.1b-NT$610,218,000.0032.9x-72.5x21.3x
Mon, 15 Jan 2024NT$44.9bNT$2.1b-NT$610,218,000.0033.3x-73.6x21.6x
Wed, 13 Dec 2023NT$49.0bNT$2.1b-NT$610,218,000.0033.1x-80.3x23.6x
Fri, 10 Nov 2023NT$48.8bNT$2.2b-NT$497,769,000.0031.7x-98x21.9x
Sun, 08 Oct 2023NT$48.3bNT$2.2b-NT$497,769,000.0031.4x-97.1x21.7x
Tue, 05 Sep 2023NT$43.6bNT$2.2b-NT$497,769,000.0031.7x-87.5x19.6x
Thu, 03 Aug 2023NT$47.1bNT$2.5b-NT$274,767,000.0043x-171.3x19.2x
Sat, 01 Jul 2023NT$50.2bNT$2.5b-NT$274,767,000.0044x-182.6x20.5x
Mon, 29 May 2023NT$50.0bNT$2.5b-NT$262,467,000.0043.4x-190.4x20.2x
Wed, 26 Apr 2023NT$46.4bNT$2.7b-NT$29,761,000.0023.1x-1557.7x17.4x
Price to Earnings Ratio

-1557.7x


Total Market Cap: NT$46.4bTotal Earnings: -NT$29,761,000.00Total Revenue: NT$2.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Clinical Research and Equipment Industry Price to Earnings3Y Average -116.7x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 17.1x is higher than the industry's current PS ratio of 13.9x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Revenues have also declined 2.0% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does Taiwanese Clinical Research and Equipment compare with similar industries?

TW Market4.20%
Healthcare2.45%
Life Sciences11.76%
Clinical Research and Equipment11.76%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6891 Locus CellNT$51.1075.6%
+NT$4.4b		133.3%PS802.5x
6848 RBC BioscienceNT$19.4014.8%
+NT$32.4m		18.6%PE12.8x
4133 Abnova (Taiwan)NT$22.500.7%
+NT$9.1m		-11.2%PS3.9x
6939 TFBS BioscienceNT$20.251.3%
+NT$8.7m		-15.8%n/a
6661 Welgene BiotechLtdNT$18.651.1%
+NT$4.7m		-4.4%PE326.8x

Latest News

6848
NT$19.40
RBC Bioscience
7D
14.8%
1Y
18.6%
6891
NT$51.10
Locus Cell
7D
75.6%
1Y
133.3%
6939
NT$20.25
TFBS Bioscience
7D
1.3%
1Y
-15.8%
6986
NT$60.80
HeXun Biosciences
7D
-0.3%
1Y
-21.8%
6662
NT$30.40
BioLASCO Taiwan
7D
-1.0%
1Y
-11.9%
7837
NT$106.50
Creative Life Science
7D
-3.6%
1Y
n/a
6589
NT$50.60
EirGenix
7D
-4.3%
1Y
-19.7%
6661
NT$18.65
Welgene BiotechLtd
7D
1.1%
1Y
-4.4%
4133
NT$22.50
Abnova (Taiwan)
7D
0.7%
1Y
-11.2%